These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37059232)

  • 41. Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial.
    Simmons LAM; Kanthabalan A; Arya M; Briggs T; Barratt D; Charman SC; Freeman A; Hawkes D; Hu Y; Jameson C; McCartan N; Moore CM; Punwani S; van der Muelen J; Emberton M; Ahmed HU
    J Urol; 2018 Dec; 200(6):1227-1234. PubMed ID: 30017964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
    Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
    BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Analysis of the relationship between PI-RADS scores and the pathological results of targeted biopsy based on MRI].
    Wang YM; Shang JW; Dong L; Liang LH; Zhao RZ; Liang C; Wang SQ; Xia W; Cheng G; Hua LX
    Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):942-947. PubMed ID: 37968079
    [No Abstract]   [Full Text] [Related]  

  • 44. Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance.
    Dieffenbacher S; Nyarangi-Dix J; Giganti F; Bonekamp D; Kesch C; Müller-Wolf MB; Schütz V; Gasch C; Hatiboglu G; Hauffe M; Stenzinger A; Duensing S; Schlemmer HP; Moore CM; Hohenfellner M; Radtke JP
    Eur Urol Focus; 2021 Jan; 7(1):102-110. PubMed ID: 30878348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A systematic review and meta-analysis of magnetic resonance imaging and ultrasound guided fusion biopsy of prostate for cancer detection-Comparing transrectal with transperineal approaches.
    Loy LM; Lim GH; Leow JJ; Lee CH; Tan TW; Tan CH
    Urol Oncol; 2020 Aug; 38(8):650-660. PubMed ID: 32505458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive vs Software Fusion, A Multicenter Analysis.
    Hung M; Ross AE; Li EV; Pavlovich CP; Fletcher SA; Gereta S; Zhang TR; McClure TD; Allaf ME; Schaeffer EM; Hu JC
    Urology; 2024 Apr; 186():91-97. PubMed ID: 38387509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer detection and complications of transperineal prostate biopsy with antibiotics when indicated.
    Boevé LMS; Bloemendal FT; de Bie KCC; van Haarst EP; Krul EJT; de Bruijn JJ; Beems S; Vanhommerig JW; Hovius MC; Ruiter AEC; Lagerveld BW; van Andel G
    BJU Int; 2023 Oct; 132(4):397-403. PubMed ID: 37155185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiparametric MRI-ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic-assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy.
    Lee AYM; Yang XY; Lee HJ; Law YM; Huang HH; Lau WKO; Lee LS; Ho HSS; Tay KJ; Cheng CWS; Yuen JSP; Chen K
    BJU Int; 2020 Nov; 126(5):568-576. PubMed ID: 32438463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer.
    Shoji S
    Investig Clin Urol; 2019 Jan; 60(1):4-13. PubMed ID: 30637355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic performance of MRI/TRUS fusion-guided biopsies vs. systematic prostate biopsies in biopsy-naïve, previous negative biopsy patients and men undergoing active surveillance.
    Borghesi M; Bianchi L; Barbaresi U; Vagnoni V; Corcioni B; Gaudiano C; Fiorentino M; Giunchi F; Chessa F; Garofalo M; Bertaccini A; Angelini S; Ercolino A; Casablanca C; Droghetti M; Golfieri R; Schiavina R
    Minerva Urol Nephrol; 2021 Jun; 73(3):357-366. PubMed ID: 33769008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of complications rates between multiparametric magnetic resonance imaging-transrectal ultrasound (TRUS) fusion and systematic TRUS prostatic biopsies.
    Queiroz MRG; Falsarella PM; Mariotti GC; Lemos GC; Baroni RH; Mussi TC; Garcia RG
    Abdom Radiol (NY); 2019 Feb; 44(2):732-738. PubMed ID: 30255444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic versus Targeted Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy among Men with Visible Lesions.
    Patel HD; Koehne EL; Shea SM; Fang AM; Gorbonos A; Quek ML; Flanigan RC; Goldberg A; Rais-Bahrami S; Gupta GN
    J Urol; 2022 Jan; 207(1):108-117. PubMed ID: 34428091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Initial series of magnetic resonance imaging (MRI)-fusion targeted prostate biopsy using the first transperineal targeted platform available in the USA.
    Kosarek CD; Mahmoud AM; Eyzaguirre EJ; Shan Y; Walser EM; Horn GL; Williams SB
    BJU Int; 2018 Nov; 122(5):909-912. PubMed ID: 29569311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of In-Office MRI/US Fusion Transperineal Prostate Biopsy via Free-hand Device during Routine Clinical Practice.
    Briggs LG; Kim M; Gusev A; Rumpf F; Feldman A; McGovern F; Tabatabaei S; Dahl DM
    Urology; 2021 Sep; 155():26-32. PubMed ID: 34048827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magnetic Resonance Imaging (MRI)-Targeted Biopsy in Patients with Prostate-Specific Antigen (PSA) Levels <20 ng/mL: A Single-Center Study in Northeastern China.
    Dai Z; Liu Y; Huangfu Z; Wang L; Liu Z
    Med Sci Monit; 2021 Aug; 27():e930234. PubMed ID: 34365459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimizing Spatial Biopsy Sampling for the Detection of Prostate Cancer.
    Raman AG; Sarma KV; Raman SS; Priester AM; Mirak SA; Riskin-Jones HH; Dhinagar N; Speier W; Felker E; Sisk AE; Lu D; Kinnaird A; Reiter RE; Marks LS; Arnold CW
    J Urol; 2021 Sep; 206(3):595-603. PubMed ID: 33908801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1).
    Ploussard G; Barret E; Fiard G; Lenfant L; Malavaud B; Giannarini G; Almeras C; Aziza R; Renard-Penna R; Descotes JL; Rozet F; Beauval JB; Salin A; Rouprêt M
    Eur Urol Oncol; 2024 Feb; ():. PubMed ID: 38403523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging-Reporting and Data System (PI-RADS) 3-5 MRI lesions.
    Yaxley AJ; Yaxley JW; Thangasamy IA; Ballard E; Pokorny MR
    BJU Int; 2017 Nov; 120 Suppl 3():43-50. PubMed ID: 28749035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Magnetic resonance imaging /ultrasonography fusion transperineal prostate biopsy for prostate cancer: Initial experience at a Middle Eastern tertiary medical centre.
    El-Achkar A; Al-Mousawy M; Abou Heidar N; Moukaddem H; Hussein H; Mouallem N; El-Hajj A; Bulbul M
    Arab J Urol; 2021; 19(4):454-459. PubMed ID: 34881061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
    Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
    J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.